Trade Names: | |
Synonyms: | |
Status: | Approved (1996) |
Entry Type: | Small molecule |
Molecule Category: | Salt |
UNII: | B53E3NMY5C |
Parent Compound: | TIZANIDINE |
InChI Key | ZWUKMNZJRDGCTQ-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C9H9Cl2N5S |
Molecular Weight | 290.18 |
AlogP | 1.72 |
Hydrogen Bond Acceptor | 6.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 62.2 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 16.0 |
Action | Mechanism of Action | Reference |
---|---|---|
AGONIST | Adrenergic receptor alpha-2 agonist | DailyMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Radiculopathy | 3 | D011843 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Brain Injuries | 1 | D001930 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 9609 |
ChEMBL | CHEMBL1200329 |
EPA CompTox | DTXSID9046990 |
FDA SRS | B53E3NMY5C |
Guide to Pharmacology | 7308 |
KEGG | C07452 |
PubChem | 114869 |
SureChEMBL | SCHEMBL41199 |
ZINC | ZINC19702309 |